T2 biosystems stocktwits.

Discover T2 Biosystems Inc (TTOO) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits communityT2 will have its second quarter report out on Tuesday, August 11 after the bell, but already last month released its preliminary numbers -- and they look good: Estimated second quarter 2020 total revenue is expected to be in the range of $2.4 million to $2.6 million, compared to $1.8 million in the prior year period. T2 Biosystems, Inc. Common Stock (TTOO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Stock analysis for T2 Biosystems Inc (TTOO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

1.09. -0.02. -1.80%. Get T2 Biosystems Inc (TTOO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

T2 Biosystems itself only has 9.43% of its floated shares sold short. But higher-priced stocks tend to be less volatile, making them more attractive to short-sellers.Get the latest Vistagen Therapeutics Inc (VTGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

T2 Biosystems sentiment based on opinions from InvestorPlace, Stocktwits and others. Sentiment for T2 Biosystems is 34.26% less bearish than other Healthcare sector stocks.T2 Biosystems has multiple diagnostic applications in development, all designed to enable further breakthroughs in rapid and accurate therapy for patients. The diagnostics are focused on critical, unmet needs in healthcare, where solutions can serve a dual role of improving patient care while reducing costs. T2Resistance® Panel: T2 Biosystems ...Thinking about buying stock in T2 Biosystems, Mullen Automotive, Genius Group, Crown Electrokinetics., or Tellurian? PR Newswire NEW YORK, Aug. 25, 2023 NEW YORK, Aug. 25, 2023... Crown Electrokinetics Provides Second Quarter Business Update Accesswire • about 2 months agoGet the latest T2 Biosystems Inc (TTOO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Discover historical prices for TTOO stock on Yahoo Finance. View daily, weekly or monthly format back to when T2 Biosystems, Inc. stock was issued.

101 Hartwell Avenue. Lexington, MA 02421. Phone: 781-457-1200. Fax: 781-357-3080. Email Us. BARDA Contract will advance technology for the diagnosis and treatment of bloodstream infections T2 Biosystems has been awarded a milestone-based contract from the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the ...

4m. S hares of T2 Biosystems ( NASDAQ: TTOO) were trading 52% lower on an adjusted-share basis Friday, the day after the biotech company released its Q3 preliminary financial results and announced ...T2 Biosystems Inc. Watch list Set a price target alert After Hours Last Updated: Oct 12, 2023 7:59 p.m. EDT Delayed quote $ 0.1085 -0.07 -37.64% After Hours Volume: 75.1M Advanced Charting... T2 Biosystems, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022. Mar. 16. CI. Earnings Flash (TTOO) T2 BIOSYSTEMS Reports Q4 Revenue $5.5M, vs. Street Est of $5.4M. Mar. 13. MT. T2 Biosystems, Inc. Provides Revenue Guidance for the Full Year of 2023. Mar. 13.LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Company’s board of directors (the “Board”) has approved a reverse stock split of its common stock at a ratio of 1 post-split share for every 100 pre-split shares. T2 Biosystems has multiple diagnostic applications in development, all designed to enable further breakthroughs in rapid and accurate therapy for patients. The diagnostics are focused on critical, unmet needs in healthcare, where solutions can serve a dual role of improving patient care while reducing costs. T2Resistance® Panel: T2 Biosystems ...T2 Biosystems will likely see a similar drawdown (at least without positive FDA news). The company is popular among retail traders, and a sudden price decrease will cause many to lose interest ...141.43%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 9.34M. 256.85%. Get the latest Volcon Inc (VLCN) real-time ...

T2 Biosystems shares plummeted 47% to $9.19 on forecasts of lower revenue in the third-quarter. The stock is down 93% on the year so far. Trading was paused for …T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat …Date. Title. 10/06/23. T2 Biosystems Reports Granting of Inducement Award. 10/05/23. T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023. 09/19/23. T2 Biosystems Receives FDA 510 (k) Clearance for the T2Biothreat Panel. 09/15/23.LEXINGTON, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has submitted an application with the U.S. Food and Drug Administration (FDA) for Breakthrough Device Designation for the …Sep 11, 2023 · T2 Biosystems will likely see a similar drawdown (at least without positive FDA news). The company is popular among retail traders, and a sudden price decrease will cause many to lose interest. TTOO T2 Biosystems Options Ahead of Earnings Looking at the TTOO T2 Biosystems options chain, i would buy the $2.5 strike price Calls with 2023-5-19 expiration date for about $1.20 premium. If the options turn out to be profitable Before the earnings release, i would sell at least 50%. Looking forward to read your opinion about it.

Sep 11, 2023 · T2 Biosystems will likely see a similar drawdown (at least without positive FDA news). The company is popular among retail traders, and a sudden price decrease will cause many to lose interest.

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -25.81M. -105.28%. Get the latest Athersys Inc (ATHX) real-time quote, historical ...Mar 31, 2023 · Chairman and Chief Executive Officer. John Sperzel joined T2 Biosystems as President and Chief Executive Officer, as well as a member of our Board of Directors in January 2020. Prior to that, he served as President and CEO of Chembio Diagnostics, Inc. (NASDAQ: CEMI), a leading point-of-care diagnostics company focused on infectious diseases ... Stock analysis for T2 Biosystems Inc (TTOO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.T2 Biosystems (TTOO) is scheduled to announce Q2 earnings results on Monday, August 15th, after market close.The consensus EPS Estimate is -$0.09 and the consensus Revenue Estimate...A high-level overview of T2 Biosystems, Inc. (TTOO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.T2 Biosystems Inc. Watch list Set a price target alert After Hours Last Updated: Oct 12, 2023 7:59 p.m. EDT Delayed quote $ 0.1085 -0.07 -37.64% After Hours Volume: 75.1M Advanced Charting...Unternehmensprofil. T2 Biosystems, Inc. ist ein Unternehmen für In-vitro-Diagnostik. Das Unternehmen konzentriert sich auf den Nachweis von Sepsis verursachenden Krankheitserregern und Antibiotikaresistenzgenen. Das Unternehmen nutzt seine T2MR-Technologie, die den schnellen Nachweis von Krankheitserregern, …T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most expensive conditions in hospitals today. The T2Dx Instrument and T2Candida Panel have received marketing authorization from the U.S. Food and Drug Administration. All other T2 Biosystems products are considered ...Oct 6, 2023 · Oct 2. CR Group discloses sale of 13M T2 Biosystems shares. Sep 28. CR Group discloses sale of another 250,000 T2 Biosystems shares. Sep 27. CR Group sells another $1.3M shares in T2 Biosystems, shares fall. Sep 26. T2 Biosystems investor CR Group sells $1.9M in common stock. Sep 26.

19 jam yang lalu ... Share on Stocktwits. T2 Biosystems logo Analysts at StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO – Get Free Report) ...

T2 Biosystems Inc (TTOO) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News 2.79% 0.57% 3.56% 8.16% 0.07% 2.81% Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or remove ads. Home Symbol TTOO TTOO T2 Biosystems Inc 54,322 Watch Alerts $17.40 $13.60 (43.87%) Today $10.85 6.55

T2 Biosystems, Inc. (NASDAQ:TTOO Get Free Report) saw unusually large options trading activity on Thursday. Stock investors acquired 4,035 call options on the company. This …On October 13, 2023, T2 Biosystems Inc saw a decline in its stock performance. According to data from CNN Money, the two analysts offering 12-month price forecasts for T2 Biosystems Inc had a median target of 0.15, with a high …Jul 12, 2023 · LEXINGTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced ... Find the latest T2 Biosystems, Inc. (TTOO) stock quote, history, news and other vital information to help you with your stock trading and investing.LOS ANGELES, Oct. 13, 2023-- Southern California Gas Co. (SoCalGas) today issued the following statement in support of the U.S. Department of Energy's decision to award California up to $1.2 billion for a regional clean hydrogen hub [1].SoCalGas is a proud partner of the Alliance for Renewable Clean Hydrogen Energy Systems (ARCHES), the statewide public-private partnership and the organizer ...T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before. T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most ...T2 Biosystems, Inc. (TTOO) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 8.20 -9.20 (-52.87%) Shares of T2 Biosystems ( TTOO 35.67%) are soaring through the roof on Tuesday, after the company announced good news regarding its T2SARS-CoV-2 Panel, a test kit that can detect the SARS-CoV-2 ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping ...

In 2014, Massachusetts-based T2 Biosystems (NASDAQ: TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion ...LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Company’s board of directors (the “Board”) has approved a reverse stock split of its common stock at a ratio …T2 Biosystems ( TTOO) stock is soaring for the second day in a row. On Monday, the company announced that the Nasdaq exchange had given the company …Instagram:https://instagram. publix super market at shoppes at pelican landingpregnant belly expansion giftimber tops cabinspioneer woman guajillo pot roast About T2 Biosystems Inc. t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our … burkle and mainhallmark stars male In 2014, Massachusetts-based T2 Biosystems (NASDAQ:TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion industry ...Sep 29, 2023 · T2 Biosystems shares are up more than 20% in early trading Friday, though the stock remains down 12% over the last five days. According to an SEC filing, CR Group L.P. sold another 5 million ... videos of boils popping Complete T2 Biosystems Inc. stock information by Barron's. View real-time TTOO stock price and news, along with industry-best analysis. Date. Title. 10/06/23. T2 Biosystems Reports Granting of Inducement Award. 10/05/23. T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023. 09/19/23. T2 Biosystems Receives FDA 510 (k) Clearance for the T2Biothreat Panel. 09/15/23.